• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Emeren Group Ltd filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    4/28/25 8:53:41 PM ET
    $SOL
    Semiconductors
    Technology
    Get the next $SOL alert in real time by email
    false 0001417892 00-0000000 0001417892 2025-04-28 2025-04-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

     

    FORM 8-K

     

     

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): April 28, 2025

     

     

     

    EMEREN GROUP LTD

    (Exact name of Registrant as Specified in Its Charter)

     

     

     

    British Virgin Islands 001-33911 N/A
    (State or Other Jurisdiction
    of Incorporation)
    (Commission File Number) (IRS Employer
    Identification No.)

     

    149 Water Street, Suite 302

    Norwalk, Connecticut

    06854
    (Address of Principal Executive Offices) (Zip Code)

     

    Registrant’s Telephone Number, Including Area Code: +1 925-425-7335

     

    (Former Name or Former Address, if Changed Since Last Report.)

     

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading
    Symbol(s)
      Name of each exchange on which registered
    American Depositary Shares, each representing 10 shares, no par value per share   SOL   New York Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

     

    Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

      

     

     

     

     

    Item 8.01 Other Events.

     

    The document attached as Exhibit 99.1 to this Current Report on Form 8-K is hereby incorporated by reference into this Item 8.01.

     

     

     

     

     Item 9.01 Financial Statement and Exhibits

     

    Exhibits Index

     

    Exhibit No.   Description
         
    99.1   Press Release issued by Emeren Group Ltd on April 28, 2025
         
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      EMEREN GROUP LTD
         
    Date: April 28, 2025 By: /s/ Ke Chen
        Ke Chen
        Chief Financial Officer

     

     

     

    Get the next $SOL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SOL

    DatePrice TargetRatingAnalyst
    5/24/2024Market Perform → Under Perform
    Northland Capital
    11/22/2023$6.00 → $3.20Outperform → Market Perform
    Northland Capital
    9/13/2022$8.00Outperform
    Northland Capital
    1/5/2022$7.70 → $10.00Neutral → Buy
    ROTH Capital
    1/4/2022$12.50Outperform → Strong Buy
    Raymond James
    10/5/2021$14.50 → $12.50Outperform
    Raymond James
    9/1/2021$8.19 → $7.70Neutral
    Roth Capital
    More analyst ratings